BUSINESS
L&T Infotech – Why this is the right pick for growth-hungry investors
With its presence across the value chain, L&T Infotech is in a vantage position to ride the strong demand environment
BUSINESS
A soft quarter again, but HCL Tech is running high on stock value
The temporary softness in the stock of HCL Tech after two consecutive quarters has made the valuation enticing, seen in the context of the medium-term growth outlook and the valuation discount to larger peers
BUSINESS
Wipro: Turnaround plays out, acceleration unfolding
The positive surprise in Wipro’s Q1FY22 earnings report reiterates the fact that the bold bets of the new CEO and the razor-sharp focus on growth are paying off
BUSINESS
Infosys reaps strong demand gains, handles supply challenges smartly
We see a strong highway of growth for Infosys and recommend adding the stock on every decline
BUSINESS
Mindtree – A great start to FY22
Mindtree is a long-term winner in this technology up-cycle and should be added on every decline
BUSINESS
TCS – A soft quarter does not take away the long-term investment case
We see strong tailwind for this technology bellwether and this should translate into steady predictable earnings growth. TCS is a core portfolio stock to be added in the current weak phase
BUSINESS
What is the true worth of IRCTC?
IRCTC's unique offering of several promising businesses under one umbrella would continue to enjoy a 'scarcity premium'
BUSINESS
Can the waning impact of second wave help Ujjivan SFB re-rate?
High slippage and provision will keep most investors on the sidelines, risk-takers should start looking at the stock of Ujjivan SFB, which is now available at a huge discount to its IPO valuation
BUSINESS
Karur Vysya Bank: Valuation deserves a closer look
Karur Vysya Bank's valuation offers downside support
BUSINESS
Zensar – A turnaround road map in place
The upside may be meaningful in Zensar, but it is uncertain and warrants patience. However, the valuation discount makes it a worthy bet for the risk-taker
BUSINESS
EaseMyTrip – An outlier in a distressed industry
The stock of EaseMy Trip should, at the minimum, deliver return mimicking the earnings growth. Further, multiple re-rating remains a possibility for an Internet-based business deriving operating leverage with scale
BUSINESS
Can Equitas SFB weather the second wave of the pandemic?
As the situation improves, we expect the stock of Equitas SFB to gradually re-rate
BUSINESS
Is there any more upside in Shriram Transport?
Should the market momentum sustain, 35-40 per cent upside is in store for investors in Shriram Transport
BUSINESS
M&M Finance promises to go far. This is why
Should M&M Finance re-rate to pre-pandemic levels, a meaningful 30 per cent upside is in store in the next one year
BUSINESS
Muthoot Finance: Gold financing takes on more shine, stock reasonably priced
Given the secured and high return ratio business, we see re-rating of Muthoot Finance ahead
BUSINESS
Suryoday corrected a lot post listing – Is it time to buy?
Suryoday SFB is a business which is going through challenges and would revive once the COVID dust settles. We recommend that investors with moderate risk appetite should gradually start adding the stock for the long term
BUSINESS
Rising stocks, deadly second wave: What’s happening?
For Indian equities, the long-term structural liquidity support is hard to ignore and any correction will therefore be short-lived
TRENDS
VIP Industries – Can it retain its numero uno position, post pandemic?
While its listed peer has a robust model to withstand near-term down trading, VIP with a complete product range across price points, is ideally positioned to reap the fruits of a complete recovery. Thus any weakness should be used to gradually add this stock for the long term.
TRENDS
Zensar – A high risk bet for the patient investor
While the upside in Zensar may be meaningful, it is uncertain and warrants patience. However, the valuation discount makes it a worthy bet for the risk taker
BUSINESS
Mas Financial – Time to add a good business in a soft patch?
With the lacklustre performance of the stock, the valuation has corrected to a level that prevailed at the time of its IPO in 2017. The coming weak period of Mas Financial is an opportunity for long-term investors to add the stock
BUSINESS
Federal Bank – The cheapest for the quality it offers
Given the challenges in the financial system plagued with asset quality woes and inadequate capital, we see Federal Bank as a long-term winner with its conscious approach to diversify and de-risk the asset book and build a solid deposit base.
BUSINESS
Safari – Why the coming weak phase is the best time to add this stock
The long-term macro drivers are in place for Safari despite the temporary disruption
BUSINESS
Herd Immunity Part 2: Is the race a sprint or a marathon?
In terms of Fauci’s estimated threshold (70 percent) for herd immunity, India might reach that goal by mid-November.
TRENDS
Herd Immunity Part 1: Why the markets are not feeling the pain of the second wave
With markets making a wild swing from despondency to euphoria last year, investors do not want to miss a recovery rally this time around and are exercising patience in the hope of a better second half
